End of a slump? After four days of going down, Astrazeneca up 0.53% yesterday

Published: January 26 2023, 06:06 GMT+0

End of a slump? After four days of going down, Astrazeneca up 0.53% yesterday

Yesterday at a glance: after closing at $66.28 on Tuesday, Astrazeneca PLC maintained a strong bullish bias that helped the stock close higher at $66.63 yesterday. However, market bears ensured the the pharma giant topped out at $66.91 and that by the end of the session, the market had marked out a distinct $65.85 to $66.91 range.

  • The volume of trade was 5.26 million shares, close to the daily average of 5.26 million shares.

With around 8 hours until market open on the New York Stock Exchange, yesterday's session was notable in that S&P 500 performed relatively strongly, finishing the day at 4,016.22. Astrazeneca went up yesterday and similar gains were seen throughout the Healthcare sector (up 0.136%).

The British-Swedish pharmaceutical company is now trading 7.43% below the significant high of $71.6 it set around 16 days ago. So far this year, it has been under-performing the S&P 500 by 9.18%. Astrazeneca's market cap is currently $213.32 billion with an average daily trading volume of 5.26 million shares. Astrazeneca expected revenue of $10.91 billion with an EPS of 77 cents.

A look at other health care stocks also showed bullish price action as Bristol-Myers Squibb Company was up 1.15%. Pfizer was up 0.81%.

While Astrazeneca was bullish yesterday, the following health care stocks underperformed: Abbott Laboratories went down to $111, losing 1.36% after it closed at $112.53 yesterday.